Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking
Claire Lugnier, Hayder M. Al‐kuraishy, Éric Rousseau
Biochemical Pharmacology (2021) Vol. 185, pp. 114431-114431
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohamd A. Alblihed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 107
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
Letizia Crocetti, Giuseppe Floresta, Agostino Cilibrizzi, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4964-4964
Open Access | Times Cited: 73
Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice
Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Open Access | Times Cited: 1
The potential role of neopterin in Covid-19: a new perspective
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 11, pp. 4161-4166
Open Access | Times Cited: 68
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Naeem F. Qusty, et al.
Pulmonary Pharmacology & Therapeutics (2021) Vol. 67, pp. 102008-102008
Open Access | Times Cited: 61
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaaser Q. Almulaiky, et al.
European Journal of Pharmacology (2021) Vol. 904, pp. 174196-174196
Open Access | Times Cited: 60
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Hani Faidah, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2017-2026
Open Access | Times Cited: 57
Niclosamide for Covid-19: bridging the gap
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8195-8202
Open Access | Times Cited: 56
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
Clinical Implication of Phosphodiesterase-4-Inhibition
Martin A. Schick, Nicolas Schlegel
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1209-1209
Open Access | Times Cited: 46
Hemolytic anemia in COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Annals of Hematology (2022) Vol. 101, Iss. 9, pp. 1887-1895
Open Access | Times Cited: 43
The possible role of ursolic acid in Covid-19: A real game changer
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gaber El‐Saber Batiha
Clinical Nutrition ESPEN (2022) Vol. 47, pp. 414-417
Open Access | Times Cited: 41
Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 38
Covid-19 and development of heart failure: mystery and truth
Hope Onohuean, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2013-2021
Open Access | Times Cited: 53
Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Safaa Qusti, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112193-112193
Open Access | Times Cited: 46
Impact of Sitagliptin on Non-diabetic Covid-19 Patients
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 4, pp. 683-692
Closed Access | Times Cited: 41
The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
Claire Lugnier
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10616-10616
Open Access | Times Cited: 31
SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl− accumulation in respiratory epithelium
Lei Chen, Wei‐jie Guan, Zhuo-Er Qiu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
The role of berberine in Covid-19: potential adjunct therapy
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2003-2016
Open Access | Times Cited: 30
Ginkgo biloba in the management of the COVID‐19 severity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Open Access | Times Cited: 27
The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 6
PDE4B Modulates Phosphorylation of p65 (Ser468) via cAMP/PKA in Acute Lung Injury
Rana Dhar, Yajun Li, Zhengqiang Hu, et al.
Lung (2025) Vol. 203, Iss. 1
Closed Access
Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
Amany Magdy Beshbishy, Victor B. Oti, Diaa E. Hussein, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 34
Levamisole Therapy in COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Viral Immunology (2021) Vol. 34, Iss. 10, pp. 722-725
Closed Access | Times Cited: 33
Vinpocetine is the Forthcoming Adjuvant Agent in the Management of COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Muyiwa Samuel Fageyinbo, et al.
Future Science OA (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top